CVS Health Corp.
CVS | NYSE
$87.83
-$1.01 (-1.14%)
Sep 21, 2026, 12:10 PM ET · Market open
Market Data
Market Cap $113.35B
Enterprise Value $175.7B
Beta 0.58
Average Volume 8.06M
Shares Outstanding (Diluted) 1.28B
Shares Change YoY 1.02%
Institutional Ownership 86.83%
Exchange NYSE
ISIN US1266501006
Price Performance
Price Change 1M -7.2%
Price Change 3M -12.3%
Price Change 6M 24.6%
Price Change YTD 10.9%
Price Change 1Y 19.4%
Price Change 3Y 24.9%
Price Change 5Y 4.9%
1M CAGR (ann.) -7.7%
1Y CAGR (ann.) 23.9%
5Y CAGR (ann.) 4.6%
All-Time CAGR 7.7%
Valuation
PE Ratio 23.50
Forward PE 10.32
PEG Ratio 3.63
Forward PEG 3.79
PS Ratio 0.27
Forward PS 0.30
PB Ratio 1.42
P/FCF Ratio 7.48
P/Adj. FCF Ratio 7.78
P/OCF Ratio 7.67
EV/Sales 0.42
EV/EBIT 19.77
EV/EBITDA 14.30
EV/FCF 11.59
Earnings Yield 4.3%
FCF Yield 13.4%
Adj. FCF Yield 12.9%
Financial Health
Net Debt $47.45B
Total Debt $76.31B
Cash & Short-Term Investments $13.96B
Total Assets $253.77B
Current Ratio 0.87
Quick Ratio 0.66
Debt / Equity Ratio 0.96
Debt / EBITDA 6.21
Debt / FCF 5.03
OCF / Debt 0.25
Interest Coverage 2.67
Altman Z-Score 2.45
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 14.2%
Operating Profit Margin 2.0%
EBITDA Margin 3.2%
Net Profit Margin 1.2%
FCF Margin 3.6%
Adj. FCF Margin 3.5%
SBC / Revenue 0.1%
SBC Impact (per share) -3.8%
Returns
Return on Assets 1.9%
Return on Equity 6.4%
Return on Invested Capital 4.1%
Return on Capital Employed 5.0%
Return on Tangible Assets 3.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 7.0%
Revenue CAGR 5Y 8.3%
Revenue CAGR 10Y 9.6%
EPS CAGR 3Y 17.8%
EPS CAGR 5Y -7.1%
EPS CAGR 10Y -1.4%
FCF CAGR 3Y -5.0%
FCF CAGR 5Y 5.5%
FCF CAGR 10Y 8.1%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 41
EPS Growth Next 3Y 41.6%
Revenue Growth Next 3Y 4.5%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number $72.98
Graham Upside -17.9%
Lynch Fair Value $18.90
Lynch Upside -78.7%
Price Target $111.20
Price Target Upside 25.2%
Cash Flow
Operating Cash Flow $19.03B
Free Cash Flow $15.16B
Adj. Free Cash Flow $14.58B
FCF Per Share $9.21
OCF Per Share $11.58
OCF/S Ratio 3.6%
Income Statement
Revenue $415.09B
Gross Profit $58.75B
Operating Income $8.29B
EBITDA $12.29B
Net Income $4.91B
EPS (Diluted) $3.78
Revenue / Employee $1.6M
Profit / Employee $18.91K
Employees 259,500
Dividends
Annual Dividend $2.66
Dividend Yield 2.99%
Payout Ratio 70.4%
FCF Payout Ratio 28.1%
Adj. FCF Payout Ratio 29.3%
Dividend Growth (YoY) 0.0%
Pay Frequency Quarterly
Ex-Dividend Date Jul 22, 2026
Add to Watchlist
Select watchlists to add or remove CVS